{"id":181281,"name":"HEALTHCARE DISTRIBUTION ALLIANCE (HEALTHCARE DISTRIBUTION MANAGMENT ASSN.)","slug":"healthcare-distribution-alliance-healthcare-distribution-managment-assn","state":"VA","country":"United States of America","description":"","totalSpending":2880000,"filings":36,"yearlySpending":[{"year":2018,"income":320000},{"year":2019,"income":320000},{"year":2020,"income":400000},{"year":2021,"income":320000},{"year":2022,"income":480000},{"year":2023,"income":320000},{"year":2024,"income":320000},{"year":2025,"income":400000}],"issues":[{"code":"PHA","display":"Pharmacy"},{"code":"TAX","display":"Taxation/Internal Revenue Code"},{"code":"HCR","display":"Health Issues"},{"code":"BUD","display":"Budget/Appropriations"},{"code":"MMM","display":"Medicare/Medicaid"}],"firms":["TARPLIN, DOWNS & YOUNG, LLC"],"lobbyists":["RAISSA DOWNS","JENNIFER YOUNG","MICHELLE EASTON","ELIZABETH MURRAY","CHARLOTTE IVANCIC","PAMELA SMITH","EMILY MURRY","KIMBERLY BRANDT","MARGARET JOSEPH","PETER FISE","LAURA FRIEDEL","PARICK CARROLL"],"govEntities":["Centers For Medicare and Medicaid Services (CMS)","Food & Drug Administration (FDA)","HOUSE OF REPRESENTATIVES","SENATE","Health & Human Services, Dept of (HHS)","White House Office","Drug Enforcement Administration (DEA)"],"sampleDescriptions":["Importation of prescription drugs (S. 469, S. 771, H.R. 1776, H.R. 1245, H.R. 934, H.R. 1480, S. 92, S. 64)\n\nOpioid Drug Abuse - General issues related to opioid drug abuse\nEnsuring Patient Access and","LIFO Accounting Methodology (H.R. 1)","Pandemic All - Hazards Preparedness Act","H.R. 1625 - Consolidated Appropriations Act of 2018\nH.R. 1892 - Bipartisan Budget Act of 2018","Average Sales Price (H.R. 1920, S. 1304)\nPPACA Implementation (PL 111-148)\nCenters for Medicare and Medicaid Services (AMP and NADAC)"]}